An antibody therapy against a key inflammatory molecule involved in migraines reduces the number of headaches that chronic migraine patients experience per month in a phase III trial A new s... Read more
University of Virginia School of Medicine researchers have discovered a rare and powerful type of immune cell in the meninges around the brain, suggesting the cells may play a critical but p... Read more